| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/07/2011 | CN101233133B Hydrochlorides and hydrates of 1-[(3-cyanopyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-aminopiperidin-1-yl)xanthine, their preparation and their use as medicaments |
| 09/07/2011 | CN101204200B Pet cat beverage additive and cat beverage thereof |
| 09/07/2011 | CN101204199B Pet dog beverage additive and beverage thereof |
| 09/07/2011 | CN101161247B Potassium muriate stomach-inner retention floationg type slow release tablet prepared with shuck powder as carrier |
| 09/07/2011 | CN101156936B An administer orally mixed nucleus glycosides as well as its preparing technics |
| 09/07/2011 | CN101112457B Health-care oral liquid for slimming, reducing fat, taking good care of skin, expelling toxin and strengthening stomach |
| 09/07/2011 | CN101088498B Application of bakuchiol compound |
| 09/06/2011 | US8012996 Methods and composition for inhibition of angiogenesis |
| 09/06/2011 | US8012957 Tetrahydro-1H-1,2,6-triaza-azulene cannabinoid modulators |
| 09/06/2011 | US8012926 Amino acid composition and supplementary liquid containing the same |
| 09/06/2011 | US8012924 Amino acid composition and supplementary liquid containing the same |
| 09/06/2011 | US8012494 at least one non-ionic or zwitterionic surfactant and dispersant; improves the efficacy and/or potency of the lipase inhibitor; inter-subject variability in efficacy and/or potency is reduced, as well as the frequency and intensity of side effects |
| 09/06/2011 | US8012464 Chimeric colony stimulating factor for use in treatment and prevention of cell proliferative, blood, inflammatory and nervous system disorders |
| 09/06/2011 | CA2493785C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/06/2011 | CA2488642C Aryl carbonyl derivatives as glucokinase activators |
| 09/06/2011 | CA2465746C Hydrazono-malonitriles |
| 09/06/2011 | CA2410025C Use of biguanide derivatives for making a medicine having a wound healing effect |
| 09/06/2011 | CA2373360C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/06/2011 | CA2336361C Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 09/02/2011 | CA2716718A1 Dietary food product with reduced fat absorption |
| 09/01/2011 | WO2011106548A1 Amine polymers for use as bile acid sequestrants |
| 09/01/2011 | WO2011105912A1 Improved calcium formulation |
| 09/01/2011 | WO2011105649A1 New method for manufacturing pitavastatin hemicalcium using new intermediate |
| 09/01/2011 | WO2011105643A1 Selenalzole derivative having ligand which activates peroxisome proliferator activated receptor (ppar), preparing method thereof and usage of the chemical compounds |
| 09/01/2011 | WO2011105611A1 Ghrelin receptor agonist for treatment of dyscrasia |
| 09/01/2011 | WO2011105465A1 MAILLARD REACTION INHIBITOR, α-DICARBONYL COMPOUND DECOMPOSING AGENT, AND METHOD FOR INHIBITING THE MAILLARD REACTION |
| 09/01/2011 | WO2011105435A1 Therapeutic agent for eating disorders |
| 09/01/2011 | WO2011105099A1 Compound containing a novel 4-alkoxypyridine formation and medicine containing same |
| 09/01/2011 | WO2011104971A1 Composition for controlling weight gain and food product containing the same |
| 09/01/2011 | WO2011104687A1 Antagonist anti-il-7 receptor antibodies and methods |
| 09/01/2011 | WO2011104338A1 Halogen or cyano substituted thieno [2,3-d]pyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions |
| 09/01/2011 | WO2011104337A1 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 09/01/2011 | WO2011104334A1 4 - [cycloalkyloxy (hetero) arylamino] thieno [2, 3 - d] pyrimidines having mnkl/ mnk2 inhibiting activity for pharmaceutical compositions |
| 09/01/2011 | WO2011104298A1 Prevention and treatment of diseases caused by elevated levels of deoxy-sphingolipids |
| 09/01/2011 | WO2011059808A3 Methods for generating pancreatic tissue |
| 09/01/2011 | WO2011045732A3 A composition with enhanced thermogenic activity and the use thereof in the prevention and treatment of obesity |
| 09/01/2011 | WO2011034396A3 Solid dispersion comprising a fibrate drug, and method for preparing the solid dispersion |
| 09/01/2011 | WO2011017554A4 Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
| 09/01/2011 | WO2010141550A3 11beta-hydroxysteroid dehydrogenase type 1 (11-beta hsd1) inhibitors |
| 09/01/2011 | US20110213034 Polar Hydrophilic Prodrugs of Amphetamine and Other Stimulants and Processes for Making and Using the Same |
| 09/01/2011 | US20110213032 Fatty acid c16: 1n7-palmitoleate a lipokine and biomarker for metabolic status |
| 09/01/2011 | US20110213026 Extracts with liver-x-receptor modulators, compounds and their use especially in weight control |
| 09/01/2011 | US20110213022 Stable, water-insoluble r-(+)-alpha-lipoic acid salt useful for the treatment of diabetes mellitus and its co-morbidities |
| 09/01/2011 | US20110213021 Compositions and methods for treating nos-associated diseases |
| 09/01/2011 | US20110213004 Method of using combination preparation comprising angiotensin-ii-receptor blocker and hmg-coa reductase inhibitor |
| 09/01/2011 | US20110213002 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 09/01/2011 | US20110213000 N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases |
| 09/01/2011 | US20110212998 Pyridine derivatives as s1p1/edg1 receptor modulators |
| 09/01/2011 | US20110212996 Method to predict response to pharmacological chaperone treatment of diseases |
| 09/01/2011 | US20110212982 Administration of Dipeptidyl Peptidase Inhibitors |
| 09/01/2011 | US20110212970 Compounds that modulate intracellular calcium |
| 09/01/2011 | US20110212960 New compounds for the treatment of cns disorder |
| 09/01/2011 | US20110212958 Fatty acid raloxifene derivatives and their uses |
| 09/01/2011 | US20110212956 Pyrazolopyrimidines for treating CNS disorders |
| 09/01/2011 | US20110212954 Alpha-lipoic acid derivatives and their use in drug preparation |
| 09/01/2011 | US20110212953 Polymorph Form II of Tanaproget |
| 09/01/2011 | US20110212941 Imidazoisoindole Neuropeptide S Receptor Antagonists |
| 09/01/2011 | US20110212940 S1P Receptor Modulating Compounds and Use Thereof |
| 09/01/2011 | US20110212939 Heterocyclic GPCR Agonists |
| 09/01/2011 | US20110212938 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 |
| 09/01/2011 | US20110212925 Novel compounds as receptor modulators with therapeutic utility |
| 09/01/2011 | US20110212923 Phosphate Derivatives of Substituted Benzoxazoles |
| 09/01/2011 | US20110212919 Protein cross-linking inhibitor |
| 09/01/2011 | US20110212916 Method and means for improving bowel health |
| 09/01/2011 | US20110212910 Antioxidant |
| 09/01/2011 | US20110212905 Crystalline form of 1-(beta-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate |
| 09/01/2011 | US20110212895 Treatment of Cognitive and Learning Impairment |
| 09/01/2011 | US20110212892 Agent for treatment of diabetes |
| 09/01/2011 | US20110212891 Azepinone derivatives |
| 09/01/2011 | US20110212890 Metastin derivative and use thereof |
| 09/01/2011 | US20110212887 Methods of treating obesity using enterostatin |
| 09/01/2011 | US20110212883 Radical scavenger and active oxygen eliminating agent |
| 09/01/2011 | US20110212882 Uses of kappa opioid synthetic peptide amides |
| 09/01/2011 | US20110212529 Muscle-specific expression vectors |
| 09/01/2011 | US20110212243 Parenteral selenomethionine for production of selenium-rich foods |
| 09/01/2011 | US20110212191 Composition for the maintenance of blood sugar levels comprising cinnamon and ginseng |
| 09/01/2011 | US20110212188 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 09/01/2011 | US20110212180 Method of producing microcapsules |
| 09/01/2011 | US20110212175 Combination preparation comprising angiotensin-ii-receptor blocker and hmg-coa reductase inhibitor |
| 09/01/2011 | US20110212169 METHOD FOR PRODUCING POWDER CONTAINING NANOPARTICULATED SPARINGLY SOLUBLE DRUG, POWDER PRODUCED THEREBY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME (As Amended) |
| 09/01/2011 | US20110212166 Carnitine conjugates of adamantanamines derivatives as dual prodrugs for various uses |
| 09/01/2011 | US20110212138 Sustained release formulations using non-aqueous carriers |
| 09/01/2011 | US20110212107 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof |
| 09/01/2011 | US20110212103 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions |
| 09/01/2011 | US20110212102 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 09/01/2011 | US20110212094 Dual variable domain immunoglobulins and uses thereof |
| 09/01/2011 | US20110212092 Glucagon receptor antagonists |
| 09/01/2011 | US20110212081 Krüppel-like factors and fat regulation |
| 09/01/2011 | US20110212079 Adaptive biochemical signatures |
| 09/01/2011 | US20110212053 Phosphatidylinositol 3 kinase inhibitors |
| 09/01/2011 | US20110212052 Methods and compositions of treating and preventing autoimmune diseases |
| 09/01/2011 | US20110212051 Variants of vascular endothelial growth factor (vegf) receptor and use thereof |
| 09/01/2011 | CA2791105A1 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 09/01/2011 | CA2791103A1 4 - [cycloalkyloxy (hetero) arylamino] thieno [2,3-d] pyrimidines having mnk1/ mnk2 inhibiting activity for pharmaceutical compositions |
| 09/01/2011 | CA2790996A1 Therapeutic agent for eating disorders |
| 09/01/2011 | CA2790901A1 Amine polymers for use as bile acid sequestrants |
| 09/01/2011 | CA2789750A1 Ghrelin receptor agonist for treatment of cachexia |
| 09/01/2011 | CA2789458A1 Selenalzole derivative having ligand which activates peroxisome proliferator activated receptor (ppar), preparing method thereof and usage of the chemical compounds |
| 09/01/2011 | CA2789132A1 Antagonist il-7 receptor antibodies to treat type 2 diabetes and immunological disorders |
| 08/31/2011 | EP2362221A1 Antagonists of HMG1 for treating inflamatory conditions |